Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
BFLY 
Butterfly Network Inc (BFLY)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/17/2025: BFLY (3-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Moderate Performance
These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.
Number of Analysts
4 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $3.17
1 Year Target Price $3.17
| 4 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -54.77% | Avg. Invested days 24 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 09/17/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 410.34M USD | Price to earnings Ratio - | 1Y Target Price 3.17 |
Price to earnings Ratio - | 1Y Target Price 3.17 | ||
Volume (30-day avg) 4 | Beta 2.52 | 52 Weeks Range 1.32 - 4.98 | Updated Date 09/17/2025 |
52 Weeks Range 1.32 - 4.98 | Updated Date 09/17/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.28 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -71.78% | Operating Margin (TTM) -60.36% |
Management Effectiveness
Return on Assets (TTM) -13.72% | Return on Equity (TTM) -29.42% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 283853976 | Price to Sales(TTM) 4.69 |
Enterprise Value 283853976 | Price to Sales(TTM) 4.69 | ||
Enterprise Value to Revenue 3.24 | Enterprise Value to EBITDA -9.57 | Shares Outstanding 225314000 | Shares Floating 192637317 |
Shares Outstanding 225314000 | Shares Floating 192637317 | ||
Percent Insiders 13.92 | Percent Institutions 48 |
Upturn AI SWOT
Butterfly Network Inc
Company Overview
History and Background
Butterfly Network, Inc. was founded in 2011 with the goal of democratizing healthcare by creating a low-cost, whole-body ultrasound device. The company went public in February 2021 via a SPAC merger with Longview Acquisition Corp.
Core Business Areas
- Point-of-Care Ultrasound: Develops and commercializes the Butterfly iQ+, a handheld, single-probe, whole-body ultrasound system.
- Software and AI: Offers software and AI tools to enhance image acquisition, interpretation, and clinical workflow.
- Education and Training: Provides educational resources and training programs to help healthcare professionals effectively use their ultrasound platform.
Leadership and Structure
Dr. Todd Fruchterman is the President and CEO. The company has a standard corporate structure with functional departments such as Research and Development, Sales and Marketing, Operations, and Finance.
Top Products and Market Share
Key Offerings
- Butterfly iQ+: A handheld, whole-body ultrasound imaging device that connects to mobile devices. There is a market shift towards point-of-care ultrasound (POCUS) which is expected to propel growth for Butterfly. Competitors include Philips (PHG), GE Healthcare (GE), and Fujifilm Sonosite.
- Butterfly Cloud: A software platform for image storage, interpretation, and collaboration. This is where patient data can be shared and reviewed. No formal data available on market share or revenue from this product, but competitors include cloud solutions from the larger players. Competitors include Philips (PHG), GE Healthcare (GE), and Fujifilm Sonosite.
- Butterfly Garden: An ecosystem of education and support resources. These resources are for helping the professionals use the Butterfly product more effectively. The revenue of the Butterfly Garden is dependent on the sales and use of the Butterfly iQ+. Competitors include Philips (PHG), GE Healthcare (GE), and Fujifilm Sonosite.
Market Dynamics
Industry Overview
The ultrasound market is growing, driven by demand for point-of-care imaging and technological advancements. POCUS adoption is rising across various medical specialties.
Positioning
Butterfly Network aims to disrupt the traditional ultrasound market by offering a low-cost, portable, and easy-to-use solution. Butterfly's market position is niche in that it is trying to promote a cheaper solution for ultrasound.
Total Addressable Market (TAM)
Analysts estimate the global ultrasound market to be tens of billions of dollars. Butterfly is attempting to increase market penetration in the ultrasound and point-of-care ultrasound market. However, its market share is still small relative to other players.
Upturn SWOT Analysis
Strengths
- Low-cost ultrasound device
- Portability and ease of use
- Software and AI platform
- Strong brand recognition in POCUS
- FDA-cleared technology
Weaknesses
- Limited image quality compared to high-end systems
- Dependence on mobile devices
- Requires subscription-based model
- Financial instability and cash burn rate
- Smaller installed base
Opportunities
- Expanding into new medical specialties
- Developing AI-powered diagnostic tools
- Partnerships with healthcare providers
- Global expansion, particularly in developing countries
- Integration with telemedicine platforms
Threats
- Competition from established ultrasound manufacturers
- Technological advancements by competitors
- Changes in healthcare regulations
- Economic downturn affecting capital equipment purchases
- Reimbursement challenges
Competitors and Market Share
Key Competitors
- PHG
- GE
- FUJIY
Competitive Landscape
Butterfly Network offers a disruptive product but faces challenges from established players with larger market share, broader product portfolios, and greater financial resources.
Growth Trajectory and Initiatives
Historical Growth: Butterfly's historical growth can be assessed by examining revenue growth over the past few years. The company's growth trajectory is based on market penetration.
Future Projections: Future growth projections are based on analyst estimates for revenue and earnings growth. These estimates can be found on financial websites.
Recent Initiatives: Recent initiatives include partnerships with healthcare providers, new product releases (e.g., iQ+), and expansion into new markets.
Summary
Butterfly Network is an innovative company with a unique low-cost ultrasound device. It has a strong brand in the point-of-care segment but faces stiff competition from larger, well-established players. Its growth depends on expanding into new markets, developing innovative features, and managing financial resources effectively. The company will need to improve its financials to continue operating effectively.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company SEC Filings (10-K, 10-Q)
- Analyst Reports
- Industry Publications
- Company Website
Disclaimers:
The information provided is for informational purposes only and should not be construed as investment advice. Market share and TAM estimates are based on publicly available data and may not be precise. Financial data requires review of official company filings.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Butterfly Network Inc
Exchange NYSE | Headquaters Burlington, MA, United States | ||
IPO Launch date 2020-07-13 | CEO, President & Chairman of the Board Mr. Joseph M. DeVivo | ||
Sector Healthcare | Industry Medical Devices | Full time employees 190 | Website https://www.butterflynetwork.com |
Full time employees 190 | Website https://www.butterflynetwork.com | ||
Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. The company offers Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging on a single handheld probe integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and almost any hospital computer system; Butterfly iQ+ Bladder, a specialty product for the bladder scanning market; and Butterfly iQ+ Vet, a handheld ultrasound system designed for veterinarians. It also provides Butterfly system, which includes probes, related accessories, and software subscriptions to healthcare systems, physicians, and healthcare providers. In addition, the company offers cloud-based software solutions to healthcare systems, teleguidance, in-app educational tutorials, and formal education programs through its Butterfly Academy software and Butterfly Certified courses, as well as professional services for large scale deployments; and ScanLab, an education-only app that provides written walkthroughs and reference imagery to guide real-time educational scanning, enhancing the learning process. It sells its products through a direct sales force, distributors, and e-commerce channels. Butterfly Network, Inc. was founded in 2011 and is headquartered in Burlington, Massachusetts.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.